1. Home
  2. PTCT vs PI Comparison

PTCT vs PI Comparison

Compare PTCT & PI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTCT
  • PI
  • Stock Information
  • Founded
  • PTCT 1998
  • PI 2000
  • Country
  • PTCT United States
  • PI United States
  • Employees
  • PTCT N/A
  • PI N/A
  • Industry
  • PTCT Biotechnology: Pharmaceutical Preparations
  • PI Industrial Machinery/Components
  • Sector
  • PTCT Health Care
  • PI Technology
  • Exchange
  • PTCT Nasdaq
  • PI Nasdaq
  • Market Cap
  • PTCT 5.3B
  • PI 5.8B
  • IPO Year
  • PTCT 2013
  • PI 2016
  • Fundamental
  • Price
  • PTCT $68.31
  • PI $202.16
  • Analyst Decision
  • PTCT Buy
  • PI Buy
  • Analyst Count
  • PTCT 15
  • PI 7
  • Target Price
  • PTCT $67.67
  • PI $224.43
  • AVG Volume (30 Days)
  • PTCT 949.1K
  • PI 587.1K
  • Earning Date
  • PTCT 11-04-2025
  • PI 10-29-2025
  • Dividend Yield
  • PTCT N/A
  • PI N/A
  • EPS Growth
  • PTCT N/A
  • PI N/A
  • EPS
  • PTCT 7.72
  • PI N/A
  • Revenue
  • PTCT $1,764,929,000.00
  • PI $359,795,000.00
  • Revenue This Year
  • PTCT $119.02
  • PI $0.03
  • Revenue Next Year
  • PTCT N/A
  • PI $23.02
  • P/E Ratio
  • PTCT $8.85
  • PI N/A
  • Revenue Growth
  • PTCT 96.00
  • PI 4.24
  • 52 Week Low
  • PTCT $35.95
  • PI $60.85
  • 52 Week High
  • PTCT $69.88
  • PI $247.06
  • Technical
  • Relative Strength Index (RSI)
  • PTCT 64.81
  • PI 47.93
  • Support Level
  • PTCT $66.00
  • PI $189.68
  • Resistance Level
  • PTCT $69.88
  • PI $245.93
  • Average True Range (ATR)
  • PTCT 2.24
  • PI 13.67
  • MACD
  • PTCT -0.30
  • PI -0.65
  • Stochastic Oscillator
  • PTCT 71.61
  • PI 23.43

About PTCT PTC Therapeutics Inc.

PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The Company views its operations and manages its business in one operating segment: life science.

About PI Impinj Inc.

Impinj Inc operates a platform that enables wireless connectivity to everyday items by delivering each item's identity, location, and authenticity to business and consumer applications. Its platform includes endpoint integrated circuits (ICs) product, a miniature radios-on-a-chip, which attach to and identify their host items; and connectivity layer that comprises readers, gateways, and reader ICs to wirelessly identify, locate, authenticate, and engage endpoints via RAIN, as well as provide power to and communicate bidirectionally with endpoint ICs. Geographically, the company has a business presence in the Americas, Asia Pacific, Europe, Middle East and Africa, of which key revenue is derived from the operations in the Asia Pacific region.

Share on Social Networks: